About

On November 20, 2024, the acquisition of the Bionorica Pharmaceuticals complex, located on the territory of the Maslovsky Industrial Park in the Voronezh Region, was completed. The production and warehouse complex was built by a German company 4 years ago, has an advanced developed infrastructure, is equipped with modern production and laboratory equipment, and is certified according to GMP requirements.

Packaging

• Production area: 2 blister lines (tablets and capsules) and 1 filling line, including all necessary auxiliary rooms
• Built premises (1,000 m²) for further expansion and placement of blister lines or bottling lines.

Warehouse / Logistics / Machinery

• 2,800 pallet storage spaces, including entry and exit of vehicles.
• 125 pallet storage space for liquid bulk (hazardous substances storage warehouse).

Quality Control / Laboratory

• Analytical laboratory, stability chambers, archive samples warehouse.
• Microbiological analyses are performed in a contract laboratory.

Administrative block

• Office space for factory workers, finance department, HR, IT, etc.
• Meeting rooms.

Thanks to this transaction, VTF will significantly increase its production capacity for the production of a wide range of forms of medicines – both under the VTF brand and within the framework of contract production. This will allow VTF to continue strengthening its position in the market, creating conditions for reliable and safe provision of medicines to Russian consumers.

The acquisition of the site is a signal for foreign and Russian pharmaceutical companies that seek to localize the production of their medicines in Russia. The modern site of the company will become a reliable platform for partners interested in creating high-quality drugs in the country.